UDG Healthcare (UDHCF) Stock Price, News & Analysis

Company Overview

UDG Healthcare plc, trading on the OTCMKTS as UDHCF, is a Dublin‐based provider of outsourced services to the pharmaceutical, biotech and medical device industries. The company operates through two primary divisions: Ashfield, which delivers commercial, medical and communications services; and Sharp, which specialises in contract packaging and manufacturing solutions. Across its global network, UDG Healthcare supports clients throughout the product lifecycle, from clinical development and launch planning to ongoing marketing and patient support programs.

The Ashfield division offers a broad range of services, including field sales, market access support, medical information and scientific communications. This business unit also designs and executes training programs, digital engagement strategies and patient adherence initiatives. Sharp provides primary, secondary and serialization packaging, analytical testing and product lifecycle management services. By combining flexible manufacturing capabilities with stringent quality and regulatory compliance, Sharp helps pharmaceutical companies ensure product integrity and timely market supply.

UDG Healthcare serves clients in North America, Europe and select Asia-Pacific markets. Since its origins in the early 1990s as a specialist wholesaler and distributor of pharmaceutical products in Ireland, the company has expanded through a series of strategic acquisitions to build its current service platform. It remains headquartered in Dublin, with regional offices and facilities in key markets to maintain close collaboration with global and local healthcare customers.

Led by an executive team experienced in pharmaceutical outsourcing and life sciences, UDG Healthcare continues to pursue growth through innovation in service delivery and targeted investment in technology and talent. The company’s integrated model aims to streamline commercial operations for healthcare clients, helping them optimise efficiency, reduce time to market and improve patient outcomes.

Key Stats

• Today's Range: $14.79 to $14.79
• 50-Day Range: $14.79 to $14.79
• 52-Week Range: $10.86 to $14.79
• Volume: N/A
• Average Volume: 16,957 shs
• Market Capitalization: $3.68 billion
• P/E Ratio: N/A
• Dividend Yield: 1.28%
• Price Target: N/A
• Consensus Rating: N/A

UDHCF Stock Analysis - Frequently Asked Questions

How have UDHCF shares performed this year?

UDG Healthcare's stock was trading at $14.7867 at the start of the year. Since then, UDHCF stock has increased by 0.0% and is now trading at $14.7867.

How do I buy shares of UDG Healthcare?

Shares of UDHCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/01/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:UDHCF
• CIK: N/A
• Web: www.udghealthcare.com
• Phone: (531) 468-9000
• Fax: 353-1459-6893
• Employees: 9,000
• Year Founded: 1948

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.35
• Current Ratio: 1.90
• Quick Ratio: 1.81

Sales & Book Value

• Annual Sales: $1.28 billion
• Price / Sales: 2.87
• Cash Flow: $0.74 per share
• Price / Cash Flow: 19.91
• Book Value: $3.95 per share
• Price / Book: 3.74

Miscellaneous

• Outstanding Shares: 248,710,000
• Free Float: N/A
• Market Cap: $3.68 billion
• Optionable: Not Optionable
• Beta: 0.62